Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.56
-1.00 (-7.37%)
At close: Feb 27, 2026, 4:00 PM EST
13.00
+0.44 (3.50%)
After-hours: Feb 27, 2026, 5:36 PM EST

Phathom Pharmaceuticals Revenue

In the year 2025, Phathom Pharmaceuticals had annual revenue of $175.11M with 216.93% growth. Phathom Pharmaceuticals had revenue of $57.58M in the quarter ending December 31, 2025, with 94.12% growth.

Revenue (ttm)
$175.11M
Revenue Growth
+216.93%
P/S Ratio
5.65
Revenue / Employee
$410,094
Employees
427
Market Cap
989.71M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025175.11M119.86M216.93%
Dec 31, 202455.25M54.57M8,001.47%
Dec 31, 2023682.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortrea Holdings2.72B
MannKind348.97M
Xeris Biopharma Holdings266.14M
Valneva SE211.09M
UroGen Pharma96.52M
AbCellera Biologics75.13M
uniQure15.75M
Aktis Oncology5.56M
Revenue Rankings

PHAT News

More News